CDK7 gRNA (BRDN0001162216) Citations (1)

Originally described in: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE Nat Biotechnol. 2016 Jan 18. doi: 10.1038/nbt.3437. PubMed Journal

---

Articles Citing CDK7 gRNA (BRDN0001162216)

Articles
Lysine-specific demethylase 1 controls key OSCC preneoplasia inducer STAT3 through CDK7 phosphorylation during oncogenic progression and immunosuppression. Chakraborty AK, Raut RD, Iqbal K, Choudhury C, Alhousami T, Chogle S, Acosta AS, Fagman L, Deabold K, Takada M, Sahay B, Kumar V, Bais MV. Int J Oral Sci. 2025 Apr 17;17(1):31. doi: 10.1038/s41368-025-00363-x. PubMed

If you have published an article using this material, please email us at to have your article added to this page.